OpenAI's latest AI model is built to do far more than offer cooking advice or create a spreadsheet. GPT-Rosalind, the company's first model specifically built for life science, is meant to help scientists with drug discovery, biology and translational medicine.  The model is named after Rosalind Franklin , whose research revealed the structure of DNA and formed the foundations for modern molecular biology. Scientific research relies heavily on data, and GPT-Rosalind is designed to help sort through it, while also helping reduce the time it takes to develop and get new drugs approved and out on the market.  (Disclosure: Ziff Davis, CNET's parent company, in 2025 filed a lawsuit against OpenAI, alleging it infringed Ziff Davis copyrights in training and operating its AI systems.) It can take 10 to 15 years for a new drug to be developed and approved in the US, OpenAI said in a blog post Thursday .…